Back to Drugs

February 2003
Shopping Center World;Feb2003, Vol. 32 Issue 2, p10
Trade Publication
Reports on the increasing sales of the pharmaceutical industry in the U.S. as of February 2003. Growth of the generic drug segment; Percentage of the total revenue.


Related Articles

  • For drug makers, solid returns depend much on blockbusters.  // Drug Store News;1/20/2003, Vol. 25 Issue 1, p44 

    Reports on the increasing financial return of the brand-name drug manufacturers in Boston, Massachusetts. Escalation of sales profit; Advantages of eliminating unpromising drugs; Demand for blockbuster medications.

  • WHY DRUG COMPANIES ARE THE MOST PROFITABLE U.S. INDUSTRY.  // Health & Stress;2003, Issue 2, p1 

    Reports that pharmaceutical companies continued their supremacy as the most profitable industry the United States in 2001. Profits earned by Fortune 500 pharmaceutical companies; Shift to more expensive prescriptions; Factors that have allowed drug companies to gain substantial profits.

  • Drug industry confounds analysts' forecasts.  // Life Science Today;Jun2000, Vol. 1 Issue 3, p4 

    Focuses on the increased first quarter sales in drug industry in Europe. Percentage of the growth of sales; Impact of patent expiries on health reform; Advantage of patent protection of drugs.

  • CME spend reaches $1.4 billion; industry ups contribution. Liebman, Milton // Medical Marketing & Media;Sep2002, Vol. 37 Issue 9, p8 

    Reports on the increasing income of the Accreditation Council for Continuing Medical Education providers in the U.S. Contribution of the pharmaceutical industry; Alteration in financial reporting; Income of the publishing companies.

  • Survey Says Sales Not Enough. Gopal, Kevin // Pharmaceutical Executive;Jan2002, Vol. 22 Issue 1, p22 

    Presents the results of a survey facilitated by the Verband Forschender Arzneimittelhersteller, on the sales of pharmaceutical companies in Germany in 2001. Expected rise in sales in 2001; Percentage of respondents who said they expected sales to drop in 2002; Percentage of respondents who...

  • Old Copycats: Learn New Tricks. Desai, V. Subhash // Siliconindia;Mar2002, Vol. 6 Issue 3, p10 

    Focuses on the aspects of the pharmaceutical industry in India. Overview on the average profits and revenues of pharmaceutical companies; Complexities facing large and small pharmaceutical firms; Profitability and risks with drug discovery.

  • Negotiating and Structuring Strategic Alliances. Schulman, David; Zammit-Lucia, Joe; Easley, Chris // BioPharm International;Jun2002, Vol. 15 Issue 6, p72 

    Reports the difficulty in maintaining double-digit profit growth of pharmaceutical companies. Increase of value in determining biotechnology; Changes on the nature of biotechnology value; Generation of cash flow from technologies and products.

  • IMS Health Business Watch. Friedman, Katherine; Kulp, Katrina // Medical Marketing & Media;May2000, Vol. 35 Issue 5, p40 

    Reports on the increase in the sales for the United States pharmaceutical industry for the year 1999. Increase in sales due to increased use of medicine; Anti-ulcer drugs' domination of the market; Percentage of drug purchases from retail pharmacies.

  • Key pharmaceutical markets expect growth through 2005.  // Fairfield County Business Journal;04/16/2001, Vol. 40 Issue 16, p25 

    Focuses on the expected growth of pharmaceutical markets in Latin America. Average rate of sales expansion; Expected annual sales in Mexico; Factors affecting the pharmaceutical industry; Influence of currency changes on pharmaceutical sales; Projected healthcare market status.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics